Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 888286 | ISIN: US4262811015 | Ticker-Symbol: JHY
Tradegate
12.11.24
15:47 Uhr
167,05 Euro
+0,35
+0,21 %
Branche
IT-Dienstleistungen
Aktienmarkt
S&P 500
1-Jahres-Chart
JACK HENRY & ASSOCIATES INC Chart 1 Jahr
5-Tage-Chart
JACK HENRY & ASSOCIATES INC 5-Tage-Chart
RealtimeGeldBriefZeit
166,35169,0512.11.
166,35167,0512.11.
PR Newswire
95 Leser
Artikel bewerten:
(0)

Jack Henry & Associates, Inc. Reports First Quarter Fiscal 2025 Results

Finanznachrichten News

First quarter summary:

  • GAAP revenue increased 5.2% and GAAP operating income increased 14.0% for the fiscal three months ended September 30, 2024, compared to the prior fiscal year quarter.
  • Non-GAAP adjusted revenue increased 5.3% and non-GAAP adjusted operating income increased 1.6% for the fiscal three months ended September 30, 2024, compared to the prior fiscal year quarter.1
  • GAAP EPS was $1.63 per diluted share for the fiscal three months ended September 30, 2024, compared to $1.39 per diluted share in the prior fiscal year quarter.
  • Cash and cash equivalents were $43 million at September 30, 2024, and $31 million at September 30, 2023.
  • Debt outstanding related to credit facilities was $140 million at September 30, 2024, and $245 million at September 30, 2023.

Full year fiscal 2025 guidance:2


Current

GAAP

Low

High

Revenue

$2,369

$2,391

Operating margin3

23.0 %

23.2 %

EPS

$5.78

$5.87




Non-GAAP 4



Adjusted revenue

$2,353

$2,375

Adjusted operating margin

22.7 %

22.8 %

MONETT, Mo., Nov. 5, 2024 /PRNewswire/ -- Jack Henry & Associates, Inc. (Nasdaq: JKHY), a leading financial technology provider, today announced results for fiscal first quarter ended September 30, 2024.

Continue Reading

According to Greg Adelson, President and CEO, "We are pleased to report another quarter of solid financial performance, which was slightly better than the outlook provided in August for FY Q1. Our sales team maintained positive momentum in the quarter with a new record sales attainment for Q1 and increased our sales pipeline to an all-time high. We had an outstanding Jack Henry Connect conference last month in Phoenix, where we strengthened relationships with clients and prospects and demonstrated our execution over the past year. We are energized and remain focused on our key differentiators: culture, service, and innovation."

1 See tables below on page 4 reconciling non-GAAP financial measures to GAAP.
2 The full fiscal year guidance assumes no acquisitions or dispositions are made during fiscal year 2025.
3Operating margin is calculated by dividing operating income by revenue.
4 See tables below on page 7 reconciling fiscal year 2025 GAAP to non-GAAP guidance.
5See table below on page 12 reconciling net income to non-GAAP EBITDA.

Operating Results

Revenue, operating expenses, operating income, and net income for the three months ended September 30, 2024, compared to the three months ended September 30, 2023, were as follows:

Revenue






(Unaudited, In Thousands)

Three Months Ended

September 30,


%
Change


2024


2023



Revenue






Services and Support

$ 356,679


$ 342,205


4.2 %

Percentage of Total Revenue

59.3 %


59.9 %



Processing

244,303


229,163


6.6 %

Percentage of Total Revenue

40.7 %


40.1 %



REVENUE

$ 600,982


$ 571,368


5.2 %

  • Services and support revenue increased for the three months ended September 30, 2024, primarily driven by growth in data processing and hosting revenue of 12.6%, partially offset by a decrease in license and hardware revenue of 35.9%. Processing revenue increased for the three months ended September 30, 2024, primarily driven by growth in card revenue of 5.1% and transaction and digital revenue of 10.9%. Other drivers were increases in payment processing and remote capture and ACH revenues.
  • For the three months ended September 30, 2024, core segment revenue increased 4.9%, payments segment revenue increased 6.3%, complementary segment revenue increased 6.4%, and corporate and other segment revenue decreased 10.2%. For the three months ended September 30, 2024, core segment non-GAAP adjusted revenue increased 5.2%, payments segment non-GAAP adjusted revenue increased 5.9%, complementary segment non-GAAP adjusted revenue increased 7.1%, and corporate and other non-GAAP adjusted segment revenue decreased 10.3% (see revenue lines of segment break-out tables on pages 5 and 6 below for a reconciliation of segment non-GAAP adjusted revenue to GAAP segment revenue).

Operating Expenses and Operating Income



(Unaudited, In Thousands)

Three Months Ended

September 30,


%
Change


2024


2023



Cost of Revenue

$ 343,432


$ 323,002


6.3 %

Percentage of Total Revenue 6

57.1 %


56.5 %



Research and Development

39,686


36,892


7.6 %

Percentage of Total Revenue 6

6.6 %


6.5 %



Selling, General, and Administrative

66,588


78,774


(15.5) %

Percentage of Total Revenue 6

11.1 %


13.8 %



OPERATING EXPENSES

449,706


438,668


2.5 %







OPERATING INCOME

$ 151,276


$ 132,700


14.0 %

Operating Margin 6

25.2 %


23.2 %



  • Cost of revenue increased for the three months ended September 30, 2024, primarily due to higher direct costs generally consistent with increases in the related lines of revenue, higher personnel costs including benefits expenses from an increase in employee headcount in the trailing twelve months, higher internal licenses and fees from increased deployments and prices, and a rise in amortization from capital development projects placed into service in the trailing twelve months.
  • Research and development expense increased for the three months ended September 30, 2024, primarily due to higher personnel costs (net of capitalization) including benefits expenses from an increase in employee headcount in the trailing twelve months.
  • Selling, general, and administrative expense decreased for the three months ended September 30, 2024, primarily due to the decrease in non-recurring costs when compared to the prior fiscal year quarter.

Net Income

(Unaudited, In Thousands,

Except Per Share Data)

Three Months Ended

September 30,


%
Change


2024


2023



Income Before Income Taxes

$ 156,798


$ 133,248


17.7 %

Provision for Income Taxes

37,607


31,569


19.1 %

NET INCOME

$ 119,191


$ 101,679


17.2 %

Diluted earnings per share

$ 1.63


$ 1.39


17.1 %

  • Effective tax rates for the three months ended September 30, 2024, and 2023, were 24.0% and 23.7%, respectively.

According to Mimi Carsley, CFO and Treasurer, "For the first quarter of the fiscal year, revenue and operating margins were aligned with our plan and expectations and we continue to expect stronger performance in the second half of our fiscal year. Our private cloud revenue grew over 11% and processing services continued to drive strong revenue growth at over 6%, each contributing to our overall revenue expansion of over 5% and operating income increase of 2% on a non-GAAP basis."

6Operating margin is calculated by dividing operating income by revenue. Operating margin plus operating expense components as a percentage of total revenue may not equal 100% due to rounding.

Impact of Non-GAAP Adjustments

The tables below show our revenue, operating income, and net income for the three months ended September 30, 2024, compared to the three months ended September 30, 2023, excluding the impacts of deconversions and the VEDIP program expense.*

(Unaudited, In Thousands)

Three Months Ended
September 30,


%
Change


2024


2023









GAAP Revenue**

$ 600,982


$ 571,368


5.2 %







Adjustments:






Deconversion revenue

(3,697)


(4,136)









NON-GAAP ADJUSTED REVENUE**

$ 597,285


$ 567,232


5.3 %













GAAP Operating Income

$ 151,276


$ 132,700


14.0 %







Adjustments:






Operating income from deconversions

(3,495)


(3,755)



VEDIP program expense*

-


16,443









NON-GAAP ADJUSTED OPERATING INCOME

$ 147,781


$ 145,388


1.6 %

Non-GAAP Adjusted Operating Margin***

24.7 %


25.6 %









GAAP Net Income

$ 119,191


$ 101,679


17.2 %







Adjustments:






Net income from deconversions

(3,495)


(3,755)



VEDIP program expense*

-


16,443



Tax impact of adjustments****

839


(3,045)









NON-GAAP ADJUSTED NET INCOME

$ 116,535


$ 111,322


4.7 %


*The VEDIP program expense for the fiscal three months ended September 30, 2024, was related to a Company voluntary separation program offered to certain eligible employees beginning in July 2023.

**GAAP revenue is comprised of services and support and processing revenues (see page 2). Reducing services and support revenue by deconversion revenue for the three months ended September 30, 2024, and 2023 which was $3,697 for the current fiscal year quarter and $4,136 for the prior fiscal year quarter, results in non-GAAP adjusted services and support revenue growth of 4.4% quarter over quarter. There were no non-GAAP adjustments to processing revenue for the three months ended September 30, 2024, or 2023.

***Non-GAAP adjusted operating margin is calculated by dividing non-GAAP adjusted operating income by non-GAAP adjusted revenue.

****The tax impact of adjustments is calculated using a tax rate of 24% for the three months ended September 30, 2024, and 2023. The tax rate for non-GAAP adjustment items takes a broad look at our recurring tax adjustments and applies them to non-GAAP revenue that does not have its own specific tax impacts.

The tables below show the segment break-out of revenue and cost of revenue for each period presented, as adjusted for the items above, and include a reconciliation to non-GAAP adjusted operating income presented above.


Three Months Ended September 30, 2024

(Unaudited, In Thousands)

Core


Payments


Complementary


Corporate
and Other


Total

GAAP REVENUE

$ 195,624


$ 211,923


$ 171,702


$ 21,733


$ 600,982

Non-GAAP adjustments*

(1,287)


(1,914)


(473)


(23)


(3,697)

NON-GAAP ADJUSTED REVENUE

194,337


210,009


171,229


21,710


597,285











GAAP COST OF REVENUE

81,420


113,020


65,967


83,025


343,432

Non-GAAP adjustments*

(37)


(18)


(60)


-


(115)

NON-GAAP ADJUSTED COST OF REVENUE

81,383


113,002


65,907


83,025


343,317











GAAP SEGMENT INCOME

$ 114,204


$ 98,903


$ 105,735


$ (61,292)



Segment Income Margin**

58.4 %


46.7 %


61.6 %


(282.0) %













NON-GAAP ADJUSTED SEGMENT INCOME

$ 112,954


$ 97,007


$ 105,322


$ (61,315)



Non-GAAP Adjusted Segment Income Margin**

58.1 %


46.2 %


61.5 %


(282.4) %













Research and Development









39,686

Selling, General, and Administrative









66,588

Non-GAAP adjustments unassigned to a segment***








(87)

NON-GAAP TOTAL ADJUSTED OPERATING EXPENSES








449,504











NON-GAAP ADJUSTED OPERATING INCOME








$ 147,781


*Revenue non-GAAP adjustments for all segments were deconversion revenue. Cost of revenue non-GAAP adjustments for all segments were deconversion costs.

**Segment income margin is calculated by dividing segment income by revenue for each segment. Non-GAAP adjusted segment income margin is calculated by dividing non-GAAP adjusted segment income by non-GAAP adjusted revenue for each segment.

***Non-GAAP adjustments unassigned to a segment were selling, general, and administrative deconversion costs.


Three Months Ended September 30, 2023

(Unaudited, In Thousands)

Core


Payments


Complementary


Corporate
and Other


Total

GAAP REVENUE

$ 186,439


$ 199,358


$ 161,366


$ 24,205


$ 571,368

Non-GAAP adjustments*

(1,665)


(1,006)


(1,451)


(14)


(4,136)

NON-GAAP ADJUSTED REVENUE

184,774


198,352


159,915


24,191


567,232











GAAP COST OF REVENUE

75,927


108,826


60,957


77,292


323,002

Non-GAAP adjustments*

(103)


(47)


(119)


(1)


(270)

NON-GAAP ADJUSTED COST OF REVENUE

75,824


108,779


60,838


77,291


322,732











GAAP SEGMENT INCOME

$ 110,512


$ 90,532


$ 100,409


$ (53,087)



Segment Income Margin

59.3 %


45.4 %


62.2 %


(219.3) %













NON-GAAP ADJUSTED SEGMENT INCOME

$ 108,950


$ 89,573


$ 99,077


$ (53,100)



Non-GAAP Adjusted Segment Income Margin

59.0 %


45.2 %


62.0 %


(219.5) %













Research and Development









36,892

Selling, General, and Administrative









78,774

Non-GAAP adjustments unassigned to a segment** ***








(16,554)

NON-GAAP TOTAL ADJUSTED OPERATING EXPENSES








421,844











NON-GAAP ADJUSTED OPERATING INCOME








$ 145,388


*Revenue non-GAAP adjustments for all segments were deconversion revenues. Cost of revenue non-GAAP adjustments for all segments were deconversion costs.

**Non-GAAP adjustments unassigned to a segment were selling, general, and administrative deconversion costs of $(111) and VEDIP program expense of $(16,443).

***The VEDIP program expense for the fiscal three months ended September 30, 2023, was related to a Company voluntary separation program offered to certain eligible employees beginning in July 2023.

The table below shows our GAAP to non-GAAP guidance for the fiscal year ending June 30, 2025. Fiscal year 2025 non-GAAP guidance excludes the impacts of deconversion revenue and related operating expenses and assumes no acquisitions or dispositions are made during the fiscal year.


GAAP to Non-GAAP GUIDANCE (In Millions, except per share data)


Annual FY25




Low


High


GAAP REVENUE


$ 2,369


$ 2,391


Growth


6.9 %


7.9 %


Deconversions*


$ 16


$ 16


NON-GAAP ADJUSTED REVENUE**


$ 2,353


$ 2,375


Non-GAAP Adjusted Growth


7.0 %


8.0 %








GAAP OPERATING EXPENSES


$ 1,823


$ 1,836


Growth


5.6 %


6.4 %


Deconversion costs*


$ 3


$ 3


NON-GAAP ADJUSTED OPERATING EXPENSES**


$ 1,820


$ 1,833


Non-GAAP Adjusted Growth


6.7 %


7.4 %








GAAP OPERATING INCOME


$ 546


$ 555


Growth


11.6 %


13.3 %








GAAP OPERATING MARGIN


23.0 %


23.2 %








NON-GAAP ADJUSTED OPERATING INCOME**


$ 533


$ 542


Non-GAAP Adjusted Growth


8.2 %


9.9 %








NON-GAAP ADJUSTED OPERATING MARGIN


22.7 %


22.8 %








GAAP EPS***


$ 5.78


$ 5.87


Growth


10.6 %


12.3 %








Non-GAAP EPS***


$ 5.65


$ 5.74


Growth


7.3 %


9.0 %


*Deconversion revenue and related operating expenses are based on actual results for the three months ended September 30, 2024, and estimates for the remainder of fiscal year 2025, based on the lowest actual recent historical results. See the Company's Form 8-K filed with the Securities and Exchange Commission on October 28, 2024.

**GAAP to Non-GAAP revenue, operating expenses, and operating income may not foot due to rounding.

***The GAAP to Non-GAAP EPS reconciliation table is below on page 13.

Balance Sheet and Cash Flow Review

  • Cash and cash equivalents were $43 million at September 30, 2024, and $31 million at September 30, 2023.
  • Trade receivables were $307 million at September 30, 2024, compared to $289 million at September 30, 2023.
  • The Company had $140 million of borrowings at September 30, 2024 compared to $245 million of borrowings at September 30, 2023.
  • Deferred revenue decreased to $320 million at September 30, 2024, compared to $333 million at September 30, 2023.
  • Stockholders' equity increased to $1,925 million at September 30, 2024, compared to $1,660 million at September 30, 2023.

*See table below for Net Cash Provided by Operating Activities and on page 12 for Return on Average Shareholders' Equity. Tables reconciling the non-GAAP measures Free Cash Flow and Return on Invested Capital (ROIC) to GAAP measures are also on page 12. See the Use of Non-GAAP Financial Information section below for the definitions of Free Cash Flow and ROIC.

The following table summarizes net cash from operating activities:

(Unaudited, In Thousands)

Three Months Ended September 30,


2024


2023

Net income

$ 119,191


$ 101,679

Depreciation

11,273


12,052

Amortization

39,221


37,183

Change in deferred income taxes

(4,087)


(10,178)

Other non-cash expenses

6,678


7,037

Change in receivables

26,373


72,519

Change in deferred revenue

(69,358)


(66,322)

Change in other assets and liabilities*

(12,395)


3,169

NET CASH FROM OPERATING ACTIVITIES

$ 116,896


$ 157,139


*For the year ended September 30, 2024, includes the change in income taxes of $38,576, the change in accrued expenses of $(23,067), and the change in prepaid expenses, prepaid cost of product and other of $(18,788). For the year ended September 30, 2023, includes the change in income taxes of $39,044, the change in prepaid expenses, prepaid cost of product and other of $(17,356), and the change in accrued expenses of $(17,285).

The following table summarizes net cash from investing activities:

(Unaudited, In Thousands)

Three Months Ended September 30,


2024


2023

Capital expenditures

(12,801)


(7,612)

Proceeds from dispositions

-


852

Purchased software

(2,676)


(2,280)

Computer software developed

(42,259)


(41,486)

Purchase of investments

(2,000)


-

Proceeds from investments

1,000


-

NET CASH FROM INVESTING ACTIVITIES

$ (58,736)


$ (50,526)

The following table summarizes net cash from financing activities:

(Unaudited, In Thousands)

Three Months Ended September 30,


2024


2023

Borrowings on credit facilities

$ 75,000


$ 135,000

Repayments on credit facilities and financing leases

(85,000)


(165,000)

Purchase of treasury stock

-


(20,000)

Dividends paid

(40,104)


(37,863)

Net cash from issuance of stock and tax related to stock-based compensation

(3,128)


474

NET CASH FROM FINANCING ACTIVITIES

$ (53,232)


$ (87,389)

Use of Non-GAAP Financial Information

Generally Accepted Accounting Principles (GAAP) is the term used to refer to the standard framework of guidelines for financial accounting in the United States. GAAP includes the standards, conventions, and rules accountants follow in recording and summarizing transactions in the preparation of financial statements. In addition to reporting financial results in accordance with GAAP, we have provided certain non-GAAP financial measures, including adjusted revenue, adjusted operating income, adjusted segment income, adjusted cost of revenue, adjusted operating expenses, adjusted operating margin, adjusted segment income margin, non-GAAP earnings before interest, taxes, depreciation, and amortization (non-GAAP EBITDA), free cash flow, return on invested capital (ROIC), non-GAAP adjusted net income, and non-GAAP earnings per share (EPS).

We believe non-GAAP financial measures help investors better understand the underlying fundamentals and true operations of our business. Adjusted revenue, adjusted operating income, adjusted operating margin, adjusted segment income, adjusted segment income margin, adjusted cost of revenue, adjusted operating expenses, adjusted net income, and non-GAAP EPS eliminate one-time deconversion revenue and associated costs and the effects of the VEDIP program expense, which management believes are not indicative of the Company's operating performance. Such adjustments give investors further insight into our performance. Non-GAAP EBITDA is defined as net income attributable to the Company before the effect of interest expense, taxes, depreciation, and amortization, adjusted for net income before the effect of interest expense, taxes, depreciation, and amortization attributable to eliminated one-time deconversions and the VEDIP program expense. Free cash flow is defined as net cash from operating activities, less capitalized expenditures, internal use software, and capitalized software, plus proceeds from the sale of assets. ROIC is defined as net income divided by average invested capital, which is the average of beginning and ending long-term debt and stockholders' equity for a given period. Management believes that non-GAAP EBITDA is an important measure of the Company's overall operating performance and excludes certain costs and other transactions that management deems one time or non-operational in nature; free cash flow is useful to measure the funds generated in a given period that are available for debt service requirements and strategic capital decisions; and ROIC is a measure of the Company's allocation efficiency and effectiveness of its invested capital. For these reasons, management also uses these non-GAAP financial measures in its assessment and management of the Company's performance.

Non-GAAP financial measures used by the Company may not be comparable to similarly titled non-GAAP measures used by other companies. Non-GAAP financial measures have no standardized meaning prescribed by GAAP and therefore, are unlikely to be comparable with calculations of similar measures for other companies.

Any non-GAAP financial measures should be considered in context with the GAAP financial presentation and should not be considered in isolation or as a substitute for GAAP measures. Reconciliations of the non-GAAP financial measures to related GAAP measures are included.

Quarterly Conference Call

The Company will hold a conference call on November 6, 2024, at 7:45 a.m. Central Time, and investors are invited to listen at www.jackhenry.com. A webcast replay will be available approximately one hour after the event at ir.jackhenry.com/corporate-events-and-presentations and will remain available for one year.

About Jack Henry & Associates, Inc.®

Jack Henry (Nasdaq: JKHY) is a well-rounded financial technology company that strengthens connections between financial institutions and the people and businesses they serve. We are an S&P 500 company that prioritizes openness, collaboration, and user centricity - offering banks and credit unions a vibrant ecosystem of internally developed modern capabilities as well as the ability to integrate with leading fintechs. For more than 48 years, Jack Henry has provided technology solutions to enable clients to innovate faster, strategically differentiate, and successfully compete while serving the evolving needs of their accountholders. We empower approximately 7,500 clients with people-inspired innovation, personal service, and insight-driven solutions that help reduce the barriers to financial health. Additional information is available at www.jackhenry.com.

Statements made in this news release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, but are not limited to, those discussed in the Company's Securities and Exchange Commission filings, including the Company's most recent reports on Form 10-K and Form 10-Q, particularly under the heading Risk Factors. Any forward-looking statement made in this news release speaks only as of the date of the news release, and the Company expressly disclaims any obligation to publicly update or revise any forward-looking statement, whether because of new information, future events or otherwise.

Condensed Consolidated Statements of Income (Unaudited)

(In Thousands, except per share data)


Three Months Ended
September 30,


%
Change



2024


2023










REVENUE


$ 600,982


$ 571,368


5.2 %








Cost of Revenue


343,432


323,002


6.3 %

Research and Development


39,686


36,892


7.6 %

Selling, General, and Administrative


66,588


78,774


(15.5) %

EXPENSES


449,706


438,668


2.5 %








OPERATING INCOME


151,276


132,700


14.0 %








Interest income


8,347


4,745


75.9 %

Interest expense


(2,825)


(4,197)


(32.7) %

Interest Income (Expense), net


5,522


548


907.7 %








INCOME BEFORE INCOME TAXES


156,798


133,248


17.7 %








Provision for Income Taxes


37,607


31,569


19.1 %








NET INCOME


$ 119,191


$ 101,679


17.2 %








Diluted net income per share


$ 1.63


$ 1.39



Diluted weighted average shares outstanding


73,078


73,014










Consolidated Balance Sheet Highlights (Unaudited)

(In Thousands)


September 30,


%
Change



2024


2023



Cash and cash equivalents


$ 43,212


$ 31,467


37.3 %

Receivables


306,660


288,733


6.2 %

Total assets


2,928,511


2,734,223


7.1 %








Accounts payable and accrued expenses


$ 231,713


$ 208,909


10.9 %

Current and long-term debt


140,000


245,000


(42.9) %

Deferred revenue


319,574


333,407


(4.1) %

Stockholders' equity


1,925,028


1,659,948


16.0 %

Calculation of Non-GAAP Earnings Before Income Taxes, Depreciation and Amortization (Non-GAAP EBITDA)



Three Months Ended
September 30,


%
Change

(in thousands)


2024


2023



Net income


$ 119,191


$ 101,679



Net interest


(5,522)


(548)



Taxes


37,607


31,569



Depreciation and amortization


50,494


49,235



Less: Net income before interest expense, taxes, depreciation and

amortization attributable to eliminated one-time adjustments*


(3,495)


12,688



NON-GAAP EBITDA


$ 198,275


$ 194,623


1.9 %


*The fiscal first quarter 2025 adjustments for net income before interest expense, taxes, depreciation and amortization were for deconversions. The fiscal first quarter 2024 adjustments were for deconversions and the VEDIP program expense and were $(3,755) and $16,443, respectively.

Calculation of Free Cash Flow (Non-GAAP)


Three Months Ended
September 30,

(in thousands)


2024


2023

Net cash from operating activities


$ 116,896


$ 157,139

Capitalized expenditures


(12,801)


(7,612)

Internal use software


(2,676)


(2,280)

Proceeds from sale of assets


-


852

Capitalized software


(42,259)


(41,486)

FREE CASH FLOW


$ 59,160


$ 106,613






Calculation of the Return on Average Shareholders' Equity


September 30,

(in thousands)


2024


2023

Net income (trailing four quarters)


$ 399,328


$ 361,776

Average stockholder's equity (period beginning and ending balances)


1,792,488


1,560,543

RETURN ON AVERAGE SHAREHOLDERS' EQUITY


22.3 %


23.2 %






Calculation of Return on Invested Capital (ROIC) (Non-GAAP)


September 30,

(in thousands)


2024


2023

Net income (trailing four quarters)


$ 399,328


$ 361,776






Average stockholder's equity (period beginning and ending balances)


1,792,488


1,560,543

Average current maturities of long-term debt and financing leases

(period beginning and ending balances)


45,000


21

Average long-term debt (period beginning and ending balances)


147,500


245,000

Average invested capital


$ 1,984,988


$ 1,805,564






ROIC


20.1 %


20.0 %

GAAP to Non-GAAP EPS Reconciliation Table




FY25 Guidance



GAAP EPS

$5.78-$5.87



Excluded Activity, net of Tax:

Deconversion*

$0.13



Non-GAAP EPS

$5.65-$5.74


*We are not aware of any other discreet adjustments at this time. Deconversion revenue and related operating expenses are based on actual results for fiscal first quarter 2025 and estimates for the remainder of fiscal year 2025, based on the lowest actual recent historical results. See the Company's Form 8-K filed with the Securities and Exchange Commission on October 28, 2024.

SOURCE Jack Henry & Associates, Inc.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.